<?xml version="1.0" encoding="UTF-8"?>
<p>Subsequently, a structural study was undertaken with the NPs that exhibited the most favorable anti-mycobacterial profiles, i.e., show lower energies than the control inhibitor (
 <xref ref-type="fig" rid="molecules-26-00475-f001">Figure 1</xref>). Thus, the interaction between the bisbenzylisoquinoline alkaloids 2-nortiliacorinine, tiliacorine and 13â€²-bromotiliacorinine against the targets PknB and DprE1 were modeled.
</p>
